XML 29 R1.htm IDEA: XBRL DOCUMENT v3.20.4
Document and Entity Information - USD ($)
 12 Months Ended
Dec. 31, 2020
Feb. 28, 2021
Cover [Abstract]    
Document Type 10-K  
Document Annual Report true  
Document Transition Report false  
Document Period End Date Dec. 31, 2020  
Entity File Number 001-39539  
Entity Registrant Name PMV PHARMACEUTICALS, INC.  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 46-3218129  
Entity Address, Address Line One 8 Clarke Drive  
Entity Address, Address Line Two Suite 3  
Entity Address, City or Town Cranbury  
Entity Address, State or Province NJ  
Entity Address, Postal Zip Code 08512  
City Area Code 609  
Local Phone Number 642-6670  
Title of 12(b) Security Common stock, par value $0.00001  
Trading Symbol PMVP  
Security Exchange Name NASDAQ  
Entity Well-known Seasoned Issuer No  
Entity Voluntary Filers No  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company true  
Entity Ex Transition Period false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   44,782,566
Entity Public Float $ 1,920,312,921  
Current Fiscal Year End Date --12-31  
Document Fiscal Year Focus 2020  
Document Fiscal Period Focus FY  
Entity Central Index Key 0001699382  
Amendment Flag false  
ICFR Auditor Attestation Flag false  
Documents Incorporated by Reference

DOCUMENTS INCORPORATED BY REFERENCE

Portions of the Registrant’s definitive Proxy Statement relating to the 2021 Annual Meeting of Stockholders are incorporated herein by reference in Part III of this Annual Report on Form 10-K to the extent stated herein. The proxy statement will be filed with the Securities and Exchange Commission within 120 days of the registrant’s fiscal year ended December 31, 2020.